Corvus Pharmaceuticals, Inc. (CRVS) vs Rigel Pharmaceuticals, Inc. (RIGL)

• Corvus Pharmaceuticals, Inc. CRVS 10.57 ▲ +8.63%
• Rigel Pharmaceuticals, Inc. RIGL 39.59 ▼ −13.39%

Corvus Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Rigel Pharmaceuticals, Inc. are of similar size ($853.9M and $818.5M). Corvus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Rigel Pharmaceuticals, Inc. trades at 2.4×. Rigel Pharmaceuticals, Inc. has the higher net margin (106.6% vs 0.00%) and the higher return on invested capital (13.7% vs −352.5%). Across the 13 metrics below, Rigel Pharmaceuticals, Inc. leads on 12 and Corvus Pharmaceuticals, Inc. on 1.